TMPRSS9
protein-codingtransmembrane serine protease 9, the group of Type II transmembrane serine proteases
Gene summary
The protein encoded by this gene is a membrane-bound type II serine polyprotease that is cleaved to release three different proteases. Two of the proteases are active and can be inhibited by serine protease inhibitors, and one is thought to be catalytically inactive. This gene enhances the invasive capability of pancreatic cancer cells and may be involved in cancer progression. [provided by RefSeq, Jul 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~66.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0700092
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TMPRSS9 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001395513.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 5 | 2 | 9 | ||
| missense | 250 | 29 | 3 | 282 | ||
| nonsense | 1 | 1 | 2 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 0 | 2 | 259 | 34 | 5 | 300 |
Highest pathogenic variant AF is 0.0000049563223
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001382442.1 | 18 | MANE Select | |
| Ensembl | ENSP00000512457.1 | 18 | MANE Select | |
| RefSeq | NP_001372571.1 | 12 | Standard | |
| RefSeq | NP_892018.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- proteolysis
Molecular Function
- serine-type endopeptidase activity
Cellular Component
- integral component of plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000332578
- Coding exons
- 17
- Length
- 36469
- Individuals with no LoFs
- 125321
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 425
- Defined
- 125748
- p
- 0.00170
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.22 | 744 | 656 | 1.13 | 0.0000431 | 6647 |
| Missense (PolyPhen) | 285 | 256.14 | 1.1127 | 2596 | ||
| Synonymous | -1.79 | 336 | 297 | 1.13 | 0.0000213 | 2279 |
| Loss of Function | 1.73 | 33 | 45.6 | 0.723 | 0.00000247 | 479 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00091 | 0.00086 | rare |
| Latino/Admixed American | 0.0011 | 0.0010 | notable |
| Ashkenazi Jewish | 0.00031 | 0.00030 | rare |
| East Asian | 0.0010 | 0.0010 | notable |
| Finnish | 0.00071 | 0.00065 | rare |
| European (Non-Finnish) | 0.0026 | 0.0024 | notable |
| South Asian | 0.0020 | 0.0019 | notable |
| Other | 0.0010 | 0.00098 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Serase-1 and serase-2 are serine proteases that hydrolyze the peptides N-t-Boc-Gln-Ala-Arg-AMC and N-t-Boc-Gln- Gly-Arg-AMC. In contrast, N-t-Boc-Ala-Phe-Lys-AMC and N-t-Boc-Ala- Pro-Ala-AMC are not significantly hydrolyzed.;
Intolerance Scores
- LoFtool
- 0.0742
- RVIS EVS
- 1.65
- RVIS percentile EVS
- 96.19
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.188
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |